ArticleOncotarget2016

The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer.

Yifeng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.